to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Going global is on the wish list of many U.S. entrepreneurs, especially given the sour American economy. But how to go about it? One leading venture capitalist offers some clues.
Last week we launched a brand new program for startup companies who had previously presented at 1 Million Cups, the Kauffman Foundation's weekly educational program that features two local startups presenting to the community over coffee. This new effort, launched with the folks at Dream Big America, will continue to put a spotlight on startup companies from throughout the country.
Dominic Orr was named President and CEO of Aruba Networks in April 2006. Prior to that, Mr. Orr served as the company's Chairman of the Board. Previously, Dominic Orr was the president of Nortel Networks, Intelligent
Internet Web Systems. He previously served as the president and chief executive of Alteon WebSystems which was merged with Nortel Networks in Oct. 2000. Mr. Orr has more than 20 years of experience in the computer systems and communication
networking industry and has held senior positions at Bay Networks, Hewlett-Packard and Hughes Aircraft. Mr. Orr. is a member of the Sciences Board of Visitors at UCLA. He holds a BS in physics from City University of New York and a MS and
PhD from California Institute of Technology.
As Chief Technology Officer and Executive Vice President of Research and Development at Sun, Greg Papadopoulos directs the company's approximate $2B in R&D portfolio with an eye toward innovation, simplicity, and
eco-responsibility. With more than 20 years experience in the technology industry, Papadopoulos is responsible for managing Sun's technology decisions and architecture. His team leads Sun Labs, the DARPA High Performance Computing Systems
program, global engineering architecture, and advanced development programs. Passionate about technology and its possibilities, Papadopoulos supports open development models that stimulate communication, creativity, and innovation, which
he promotes through his blog, Greg Matter, as well as numerous speaking engagements. During his tenure with Sun, Papadopoulos has held several positions, including Vice President of Technology and Advanced Development for the company's
systems business, Chief Scientist for Server Systems Engineering, and Chief Scientist for Enterprise Servers and Storage. Before joining Sun in 1994, Papadopoulos was a senior architect and director of product strategy for Thinking
Machines, where he led the design of the CM6 massively parallel supercomputer. Papadopoulos was an associate professor of electrical engineering and computer science at MIT, where he conducted research in scalable systems, multi
threaded/data flow processor architecture, functional and declarative languages, and fault-tolerant computing. Papadopoulos also worked as a development engineer at Hewlett-Packard and Honeywell, where he designed flight-control systems
for Boeing jetliners. He co-founded three companies: PictureTel (video conferencing), Ergo (high-end PCs) and Exa Corporation (computational fluid dynamics). Papadopoulos participates in several associations, including serving as Chairman
of the Board for the Search for Extraterrestrial Intellig
Some medical device sales strategies that worked in the past are not recommended now. Read more for alternatives to boost sales for medical device startups.
Medical device startups may need an alternate strategy to address the coming changes resulting from an increased emphasis on wellness. Read more for tips.
A new report says healthcare spending will make up 20 percent of the U.S. economy by 2019. Read more on what kind of companies can take advantage of the growing healthcare business market.
A vascular access device maker has received European approval for a product designed to help people suffering from kidney failure.
Medical device startups must demonstrate a product's economic value as well as its clinical usefulness, say industry leaders. Read more about their advice for new healthcare businesses.
Getting a CE Mark in Europe has allowed American medical device makers to commercialize quickly before getting U.S. Food and Drug Administration approval to sell medical devices domestically. Read about how the less stringent European regulation methods are now being questioned.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.